[{"id":"c96f1ef4-f1ba-44e1-a4de-73dd3b7750f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT05511844","created_at":"2022-08-23T14:55:27.436Z","updated_at":"2024-07-02T16:35:12.094Z","phase":"Phase 1","brief_title":"Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors","source_id_and_acronym":"NCT05511844","lead_sponsor":"Orum Therapeutics USA, Inc.","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ORM-5029"],"overall_status":"Recruiting","enrollment":" Enrollment 87","initiation":"Initiation: 10/03/2022","start_date":" 10/03/2022","primary_txt":" Primary completion: 04/01/2025","primary_completion_date":" 04/01/2025","study_txt":" Completion: 10/01/2025","study_completion_date":" 10/01/2025","last_update_posted":"2024-04-01"}]